Report Detail
Global Biosimilar Market Insights and Forecast to 2026
- RnM4130880 |
- 12 August, 2020 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Biosimilar market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Biosimilar market is segmented into
Human Growth Hormones
Monoclonal Antibodies
Insulin
Peptides
Erythropoietin
Others
Segment by Application, the Biosimilar market is segmented into
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Regional and Country-level Analysis
The Biosimilar market is analysed and market size information is provided by regions (countries).
The key regions covered in the Biosimilar market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Biosimilar Market Share Analysis
Biosimilar market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilar business, the date to enter into the Biosimilar market, Biosimilar product introduction, recent developments, etc.
The major vendors covered:
Allergan plc
BIOCAD
Biocon
BioXpress Therapeutics
Boehringer Ingelheim
Celltrion
Coherus BioSciences
Dr. Reddy’s Laboratories
Genor BioPharma
Intas Pharmaceuticals Limited
Novartis
Pfizer
Reliance Life Sciences
1 Study Coverage
- 1.1 Biosimilar Product Introduction
- 1.2 Market Segments
- 1.3 Key Biosimilar Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Biosimilar Market Size Growth Rate by Type
- 1.4.2 Human Growth Hormones
- 1.4.3 Monoclonal Antibodies
- 1.4.4 Insulin
- 1.4.5 Peptides
- 1.4.6 Erythropoietin
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Biosimilar Market Size Growth Rate by Application
- 1.5.2 Oncology
- 1.5.3 Chronic and Autoimmune Diseases
- 1.5.4 Growth Hormone Deficiency
- 1.5.5 Infectious Diseases
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Biosimilar Market Size, Estimates and Forecasts
- 2.1.1 Global Biosimilar Revenue 2015-2026
- 2.1.2 Global Biosimilar Sales 2015-2026
- 2.2 Global Biosimilar, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Biosimilar Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Biosimilar Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biosimilar Competitor Landscape by Players
- 3.1 Biosimilar Sales by Manufacturers
- 3.1.1 Biosimilar Sales by Manufacturers (2015-2020)
- 3.1.2 Biosimilar Sales Market Share by Manufacturers (2015-2020)
- 3.2 Biosimilar Revenue by Manufacturers
- 3.2.1 Biosimilar Revenue by Manufacturers (2015-2020)
- 3.2.2 Biosimilar Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Biosimilar Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Biosimilar Revenue in 2019
- 3.2.5 Global Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Biosimilar Price by Manufacturers
- 3.4 Biosimilar Manufacturing Base Distribution, Product Types
- 3.4.1 Biosimilar Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Biosimilar Product Type
- 3.4.3 Date of International Manufacturers Enter into Biosimilar Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Biosimilar Market Size by Type (2015-2020)
- 4.1.1 Global Biosimilar Sales by Type (2015-2020)
- 4.1.2 Global Biosimilar Revenue by Type (2015-2020)
- 4.1.3 Biosimilar Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Biosimilar Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Biosimilar Sales Forecast by Type (2021-2026)
- 4.2.2 Global Biosimilar Revenue Forecast by Type (2021-2026)
- 4.2.3 Biosimilar Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Biosimilar Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Biosimilar Market Size by Application (2015-2020)
- 5.1.1 Global Biosimilar Sales by Application (2015-2020)
- 5.1.2 Global Biosimilar Revenue by Application (2015-2020)
- 5.1.3 Biosimilar Price by Application (2015-2020)
- 5.2 Biosimilar Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Biosimilar Sales Forecast by Application (2021-2026)
- 5.2.2 Global Biosimilar Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Biosimilar Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Biosimilar by Country
- 6.1.1 North America Biosimilar Sales by Country
- 6.1.2 North America Biosimilar Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Biosimilar Market Facts & Figures by Type
- 6.3 North America Biosimilar Market Facts & Figures by Application
7 Europe
- 7.1 Europe Biosimilar by Country
- 7.1.1 Europe Biosimilar Sales by Country
- 7.1.2 Europe Biosimilar Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Biosimilar Market Facts & Figures by Type
- 7.3 Europe Biosimilar Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Biosimilar by Region
- 8.1.1 Asia Pacific Biosimilar Sales by Region
- 8.1.2 Asia Pacific Biosimilar Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Biosimilar Market Facts & Figures by Type
- 8.3 Asia Pacific Biosimilar Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Biosimilar by Country
- 9.1.1 Latin America Biosimilar Sales by Country
- 9.1.2 Latin America Biosimilar Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Biosimilar Market Facts & Figures by Type
- 9.3 Central & South America Biosimilar Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Biosimilar by Country
- 10.1.1 Middle East and Africa Biosimilar Sales by Country
- 10.1.2 Middle East and Africa Biosimilar Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Biosimilar Market Facts & Figures by Type
- 10.3 Middle East and Africa Biosimilar Market Facts & Figures by Application
11 Company Profiles
- 11.1 Allergan plc
- 11.1.1 Allergan plc Corporation Information
- 11.1.2 Allergan plc Description and Business Overview
- 11.1.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Allergan plc Biosimilar Products Offered
- 11.1.5 Allergan plc Related Developments
- 11.2 BIOCAD
- 11.2.1 BIOCAD Corporation Information
- 11.2.2 BIOCAD Description and Business Overview
- 11.2.3 BIOCAD Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 BIOCAD Biosimilar Products Offered
- 11.2.5 BIOCAD Related Developments
- 11.3 Biocon
- 11.3.1 Biocon Corporation Information
- 11.3.2 Biocon Description and Business Overview
- 11.3.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Biocon Biosimilar Products Offered
- 11.3.5 Biocon Related Developments
- 11.4 BioXpress Therapeutics
- 11.4.1 BioXpress Therapeutics Corporation Information
- 11.4.2 BioXpress Therapeutics Description and Business Overview
- 11.4.3 BioXpress Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 BioXpress Therapeutics Biosimilar Products Offered
- 11.4.5 BioXpress Therapeutics Related Developments
- 11.5 Boehringer Ingelheim
- 11.5.1 Boehringer Ingelheim Corporation Information
- 11.5.2 Boehringer Ingelheim Description and Business Overview
- 11.5.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Boehringer Ingelheim Biosimilar Products Offered
- 11.5.5 Boehringer Ingelheim Related Developments
- 11.6 Celltrion
- 11.6.1 Celltrion Corporation Information
- 11.6.2 Celltrion Description and Business Overview
- 11.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Celltrion Biosimilar Products Offered
- 11.6.5 Celltrion Related Developments
- 11.7 Coherus BioSciences
- 11.7.1 Coherus BioSciences Corporation Information
- 11.7.2 Coherus BioSciences Description and Business Overview
- 11.7.3 Coherus BioSciences Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Coherus BioSciences Biosimilar Products Offered
- 11.7.5 Coherus BioSciences Related Developments
- 11.8 Dr. Reddy’s Laboratories
- 11.8.1 Dr. Reddy’s Laboratories Corporation Information
- 11.8.2 Dr. Reddy’s Laboratories Description and Business Overview
- 11.8.3 Dr. Reddy’s Laboratories Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Dr. Reddy’s Laboratories Biosimilar Products Offered
- 11.8.5 Dr. Reddy’s Laboratories Related Developments
- 11.9 Genor BioPharma
- 11.9.1 Genor BioPharma Corporation Information
- 11.9.2 Genor BioPharma Description and Business Overview
- 11.9.3 Genor BioPharma Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Genor BioPharma Biosimilar Products Offered
- 11.9.5 Genor BioPharma Related Developments
- 11.10 Intas Pharmaceuticals Limited
- 11.10.1 Intas Pharmaceuticals Limited Corporation Information
- 11.10.2 Intas Pharmaceuticals Limited Description and Business Overview
- 11.10.3 Intas Pharmaceuticals Limited Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Intas Pharmaceuticals Limited Biosimilar Products Offered
- 11.10.5 Intas Pharmaceuticals Limited Related Developments
- 11.1 Allergan plc
- 11.1.1 Allergan plc Corporation Information
- 11.1.2 Allergan plc Description and Business Overview
- 11.1.3 Allergan plc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Allergan plc Biosimilar Products Offered
- 11.1.5 Allergan plc Related Developments
- 11.12 Pfizer
- 11.12.1 Pfizer Corporation Information
- 11.12.2 Pfizer Description and Business Overview
- 11.12.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Pfizer Products Offered
- 11.12.5 Pfizer Related Developments
- 11.13 Reliance Life Sciences
- 11.13.1 Reliance Life Sciences Corporation Information
- 11.13.2 Reliance Life Sciences Description and Business Overview
- 11.13.3 Reliance Life Sciences Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Reliance Life Sciences Products Offered
- 11.13.5 Reliance Life Sciences Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Biosimilar Market Estimates and Projections by Region
- 12.1.1 Global Biosimilar Sales Forecast by Regions 2021-2026
- 12.1.2 Global Biosimilar Revenue Forecast by Regions 2021-2026
- 12.2 North America Biosimilar Market Size Forecast (2021-2026)
- 12.2.1 North America: Biosimilar Sales Forecast (2021-2026)
- 12.2.2 North America: Biosimilar Revenue Forecast (2021-2026)
- 12.2.3 North America: Biosimilar Market Size Forecast by Country (2021-2026)
- 12.3 Europe Biosimilar Market Size Forecast (2021-2026)
- 12.3.1 Europe: Biosimilar Sales Forecast (2021-2026)
- 12.3.2 Europe: Biosimilar Revenue Forecast (2021-2026)
- 12.3.3 Europe: Biosimilar Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Biosimilar Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Biosimilar Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Biosimilar Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Biosimilar Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Biosimilar Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Biosimilar Sales Forecast (2021-2026)
- 12.5.2 Latin America: Biosimilar Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Biosimilar Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Biosimilar Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Biosimilar Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Biosimilar Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Biosimilar Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Biosimilar Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Biosimilar Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Biosimilar. Industry analysis & Market Report on Biosimilar is a syndicated market report, published as Global Biosimilar Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Biosimilar market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
